Nomogram to Predict Cognitive Impairment in Patients with Asymptomatic Middle Cerebral Artery Stenosis

References

• Arenillas JF. Intracranial atherosclerosis: current concepts. Stroke. 2011;42(1 Suppl):S20–S23. doi:10.1161/STROKEAHA.110.597278
   PubMed Web of Science ®Google Scholar
• Dearborn JL, Zhang Y, Qiao Y, et al. Intracranial atherosclerosis and dementia: the Atherosclerosis Risk in Communities (ARIC) Study. Neurology. 2017;88(16):1556–1563. doi:10.1212/WNL.0000000000003837
   PubMed Web of Science ®Google Scholar
• Suri MFK, Zhou J, Qiao Y, et al. Cognitive impairment and intracranial atherosclerotic stenosis in general population. Neurology. 2018;90(14):e1240–e1247. doi:10.1212/WNL.0000000000005250
   PubMed Web of Science ®Google Scholar
• Viticchi G, Falsetti L, Potente E, Bartolini M, Silvestrini M. Impact of carotid stenosis on cerebral hemodynamic failure and cognitive impairment progression: a narrative review. Ann Transl Med. 2021;9(14):1209. doi:10.21037/atm-20-7226
   PubMed Web of Science ®Google Scholar
• Romero JR, Beiser A, Seshadri S, et al. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke. 2009;40(5):1590–1596. doi:10.1161/STROKEAHA.108.535245
   PubMed Web of Science ®Google Scholar
• Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bonaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: the Tromso Study. Neurology. 2004;62(5):695–701. doi:10.1212/01.WNL.0000113759.80877.1F
   PubMed Web of Science ®Google Scholar
• Martinić-Popović I, Lovrenčić-Huzjan A, Demarin V. Assessment of subtle cognitive impairment in stroke-free patients with carotid disease. Acta Clin Croat. 2009;48(3):231–240.
   PubMed Web of Science ®Google Scholar
• He S, Duan R, Liu Z, et al. Altered functional connectivity is related to impaired cognition in left unilateral asymptomatic carotid artery stenosis patients. BMC Neurol. 2021;21(1):350. doi:10.1186/s12883-021-02385-4
   PubMed Web of Science ®Google Scholar
• Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–2241. doi:10.1161/01.STR.0000237236.88823.47
   PubMed Web of Science ®Google Scholar
• Pergola G, Suchan B. Associative learning beyond the medial temporal lobe: many actors on the memory stage. Front Behav Neurosci. 2013;7:162. doi:10.3389/fnbeh.2013.00162
   PubMed Web of Science ®Google Scholar
• Barnes JJ, Dean AJ, Nandam LS, O’Connell RG, Bellgrove MA. The molecular genetics of executive function: role of monoamine system genes. Biol Psychiatry. 2011;69(12):e127–e143. doi:10.1016/j.biopsych.2010.12.040
   PubMed Web of Science ®Google Scholar
• Kimura S, Ogata T, Watanabe J, Inoue T, Tsuboi Y. Does cerebral large-artery disease contribute to cognitive impairment? eNeurologicalSci. 2017;8:5–8. doi:10.1016/j.ensci.2017.06.003
   PubMedGoogle Scholar
• Meng Y, Yu K, Zhang L, Liu Y. Cognitive decline in asymptomatic middle cerebral artery stenosis patients with moderate and poor collaterals: a 2-year follow-up study. Med Sci Monit. 2019;25:4051–4058. doi:10.12659/MSM.913797
   PubMed Web of Science ®Google Scholar
• Cechetti F, Pagnussat AS, Worm PV, et al. Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull. 2012;87(1):109–116. doi:10.1016/j.brainresbull.2011.10.006
   PubMed Web of Science ®Google Scholar
• Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. 2011;12(12):723–738. doi:10.1038/nrn3114
   PubMed Web of Science ®Google Scholar
• Duncombe J, Kitamura A, Hase Y, Ihara M, Kalaria RN, Horsburgh K. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin Sci. 2017;131(19):2451–2468. doi:10.1042/CS20160727
   PubMed Web of Science ®Google Scholar
• Wang W, Redecker C, Bidmon HJ, Witte OW. Delayed neuronal death and damage of GDNF family receptors in CA1 following focal cerebral ischemia. Brain Res. 2004;1023(1):92–101. doi:10.1016/j.brainres.2004.07.034
   PubMed Web of Science ®Google Scholar
• Xie M, Yi C, Luo X, et al. Glial gap junctional communication involvement in hippocampal damage after middle cerebral artery occlusion. Ann Neurol. 2011;70(1):121–132. doi:10.1002/ana.22386
   PubMed Web of Science ®Google Scholar
• Sun ZW, Zhu YX, Liu HY, et al. Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment. Eur J Neurol. 2007;14(2):150–155. doi:10.1111/j.1468-1331.2006.01579.x
   PubMed Web of Science ®Google Scholar
• Marshall RS, Pavol MA, Cheung YK, Asllani I, Lazar RM. Cognitive impairment correlates linearly with mean flow velocity by transcranial Doppler below a definable threshold. Cerebrovasc Dis Extra. 2020;10(1):21–27. doi:10.1159/000506924
   PubMed Web of Science ®Google Scholar
• de Riva N, Budohoski KP, Smielewski P, et al. Transcranial Doppler Pulsatility Index: what it is and what it isn’t. Neurocrit Care. 2012;17(1):58–66. doi:10.1007/s12028-012-9672-6
   PubMed Web of Science ®Google Scholar
• Xiao Z, Ren X, Zhao Q, et al. Relation of middle cerebral artery flow velocity and risk of cognitive decline: a prospective community-based study. J Clin Neurosci. 2022;97:56–61. doi:10.1016/j.jocn.2021.12.028
   PubMed Web of Science ®Google Scholar
• Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci. 2003;60(6):1158–1171. doi:10.1007/s00018-003-3018-7
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004;24(5):806–815. doi:10.1161/01.ATV.0000120374.59826.1b
   PubMed Web of Science ®Google Scholar
• Hua R, Ma Y, Li C, Zhong B, Xie W. Low levels of low-density lipoprotein cholesterol and cognitive decline. Sci Bull. 2021;66(16):1684–1690. doi:10.1016/j.scib.2021.02.018
   PubMed Web of Science ®Google Scholar
• Power MC, Rawlings A, Sharrett AR, et al. Association of midlife lipids with 20-year cognitive change: a cohort study. Alzheimers Dement. 2018;14(2):167–177. doi:10.1016/j.jalz.2017.07.757
   PubMed Web of Science ®Google Scholar
• An Y, Zhang X, Wang Y, et al. Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study. Mol Neurodegener. 2019;14(1):51. doi:10.1186/s13024-019-0353-1
   PubMed Web of Science ®Google Scholar
• Wu M, Zhai Y, Liang X, et al. Connecting the dots between Hypercholesterolemia and Alzheimer’s disease: a potential mechanism based on 27-hydroxycholesterol. Front Neurosci. 2022;16:842814. doi:10.3389/fnins.2022.842814
   PubMed Web of Science ®Google Scholar
• Babiker A, Dzeletovic S, Wiklund B, et al. Patients with atherosclerosis may have increased circulating levels of 27‐hydroxycholesterol and cholestenoic acid. Scand J Clin Lab Invest. 2009;65(5):365–376. doi:10.1080/00365510510025746
   Google Scholar
• Olsson AG, Angelin B, Assmann G, et al. Can LDL cholesterol be too low? Possible risks of extremely low levels. J Intern Med. 2017;281(6):534–553. doi:10.1111/joim.12614
   PubMed Web of Science ®Google Scholar
• de la Torre JC, Fortin T, Park GAS, Pappas BA, Richard MT. Brain blood flow restoration ‘rescues’ chronically damaged rat CA1 neurons. Brain Res. 1993;623(1):6–15. doi:10.1016/0006-8993(93)90003-6
   PubMed Web of Science ®Google Scholar
• Bossema ER, Brand N, Moll FL, Ackerstaff RG, van Doornen LJ. Does carotid endarterectomy improve cognitive functioning? J Vasc Surg. 2005;41(5):775–781; discussion 781. doi:10.1016/j.jvs.2004.12.057
   PubMed Web of Science ®Google Scholar
• Kwon JY, Han YS, Kim JY, et al. Intracranial artery stenting may not improve cognitive function: a preliminary study. J Stroke. 2016;18(2):227–229. doi:10.5853/jos.2015.01641
   PubMed Web of Science ®Google Scholar
• Gao P, Wang T, Wang D, et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial. JAMA. 2022;328(6):534–542. doi:10.1001/jama.2022.12000
   PubMed Web of Science ®Google Scholar